Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| PLRX (Pliant Therapeutics, Inc.) | -4.10% | -29.52% | -62.95% | -48.01% | NA | NA | NA | … | … |
Data as of 06/04/2026, Common starting date is 06/04/2020
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| PLRX (Pliant Therapeutics, Inc.) | 06/04/2020 | 06/04/2026 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -6.40 | -29.52 | -62.95 | -48.01 | NA | NA | NA | … | … | -4.10 | -90.81 | -25.12 | -6.31 | 43.19 | -40.58 | -2.74 |
| Sharpe Ratio | NA | -0.18 | -0.64 | -0.50 | NA | NA | NA | … | … | 0.13 | -0.60 | -0.55 | -0.17 | 0.35 | -0.57 | -0.06 |
| Standard Deviation(%) | NA | 60.85 | 100.35 | 98.96 | NA | NA | NA | … | … | 45.49 | 157.14 | 58.49 | 63.38 | 120.44 | 70.66 | 78.10 |
| Draw Down(%) | NA | 41.71 | 95.52 | 96.99 | NA | NA | NA | … | … | 19.26 | 91.43 | 46.30 | 64.56 | 70.85 | 69.50 | 43.59 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 06/04/2026, Common starting date is 06/04/2020
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PLRX (Pliant Therapeutics, Inc.) |
-67.44%
Jan 2023 – Jan 2026 |
-49.75%
Mar 2021 – Mar 2026 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| PLRX (Pliant Therapeutics, Inc.) |
-0.82%
Dec 2021 – Dec 2024 |
-40.01%
Oct 2020 – Oct 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart